{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:46:46Z","timestamp":1791917206580,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.hfc.2024.12.002","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:41:10Z","timestamp":1738759270000},"page":"175-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cardiac PET Imaging for Coronary Artery Disease and Heart Failure"],"prefix":"10.1016","volume":"21","author":[{"given":"Vinay","family":"Guduguntla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"48","key":"10.1016\/j.hfc.2024.12.002_bib1","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1093\/eurheartj\/ehu433","article-title":"Non-invasive cardiac imaging evaluation of patients with chronic systolic heart failure: a report from the European Association of Cardiovascular Imaging (EACVI)","volume":"35","author":"Gimelli","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2024.12.002_bib2","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2021.33","article-title":"The role of cardiac imaging in heart failure with reduced ejection fraction","volume":"8","author":"Gosling","year":"2022","journal-title":"Card Fail Rev"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.002_bib3","article-title":"Imaging to diagnose and manage patients in heart failure with reduced ejection fraction","volume":"10","author":"Nagueh","year":"2017","journal-title":"Circ: Cardiovascular Imaging"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.002_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jchf.2021.06.016","article-title":"Advanced cardiovascular imaging in clinical heart failure","volume":"9","author":"Argulian","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"10175","key":"10.1016\/j.hfc.2024.12.002_bib5","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(18)33207-0","article-title":"Multimodality imaging in ischaemic heart failure","volume":"393","author":"Bax","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.002_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcmg.2022.12.015","article-title":"Myocardial perfusion PET for the detection and reporting of coronary microvascular dysfunction","volume":"16","author":"Schindler","year":"2023","journal-title":"JACC Cardiovascular Imaging"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.002_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/jcdd10050220","article-title":"Positron emission tomography in heart failure: from pathophysiology to clinical application","volume":"10","author":"Tersalvi","year":"2023","journal-title":"JCDD"},{"key":"10.1016\/j.hfc.2024.12.002_bib8","series-title":"Braunwald\u2019s heart disease: a textbook of cardiovascular medicine","year":"2022"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.002_bib9","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.002_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2009.02.065","article-title":"Cardiac positron emission tomography","volume":"54","author":"Bengel","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.002_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11886-023-01850-5","article-title":"Advances in digital PET technology and its potential impact on myocardial perfusion and blood flow quantification","volume":"25","author":"Alahdab","year":"2023","journal-title":"Curr Cardiol Rep"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.002_bib12","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jcmg.2023.06.022","article-title":"Total-body positron emission tomography","volume":"16","author":"Cherry","year":"2023","journal-title":"JACC Cardiovascular Imaging"},{"issue":"13","key":"10.1016\/j.hfc.2024.12.002_bib13","first-page":"991","article-title":"Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: a meta-analysis","volume":"38","author":"Danad","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2024.12.002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2023.101779","article-title":"Rationale and design of the RAPID-WATER-FLOW trial: radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW","volume":"31","author":"Di Carli","year":"2024","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.12.002_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101845","article-title":"Role of 18F-sodium fluoride positron emission tomography in imaging atherosclerosis","volume":"35","author":"Kwiecinski","year":"2024","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.12.002_bib16","article-title":"Diagnostic performance of CMR, SPECT, and PET imaging for the identification of coronary artery disease: a meta-analysis","volume":"8","author":"Xu","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"18","key":"10.1016\/j.hfc.2024.12.002_bib17","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.jacc.2012.07.038","article-title":"Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?","volume":"60","author":"Mc Ardle","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.12.002_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ahj.2021.03.012","article-title":"Design and rationale of the randomized trial of comprehensive lifestyle modification, optimal pharmacological treatment and utilizing PET imaging for quantifying and managing stable coronary artery disease (the CENTURY study)","volume":"237","author":"Kitkungvan","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2024.12.002_bib19","author":"Michael"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.002_bib20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jcmg.2017.01.005","article-title":"Ischemia and viability testing in ischemic heart disease","volume":"10","author":"Panza","year":"2017","journal-title":"JACC Cardiovascular Imaging"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.002_bib21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJMoa1807365","article-title":"Myocardial viability and long-term outcomes in ischemic cardiomyopathy","volume":"381","author":"Panza","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.hfc.2024.12.002_bib22","article-title":"Long-term follow-up of outcomes with F-18-Fluorodeoxyglucose positron emission tomography imaging\u2013assisted management of patients with severe left ventricular dysfunction secondary to coronary disease","volume":"9","author":"Mc Ardle","year":"2016","journal-title":"Circ: Cardiovascular Imaging"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.002_bib23","first-page":"363","article-title":"Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus Hibernating myocardium","volume":"6","author":"Ling","year":"2013","journal-title":"Circ: Cardiovascular Imaging"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.002_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jchf.2018.01.024","article-title":"Percutaneous revascularization for ischemic ventricular dysfunction: rationale and design of the REVIVED-BCIS2 trial","volume":"6","author":"Perera","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"15","key":"10.1016\/j.hfc.2024.12.002_bib25","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.hfc.2024.12.002_bib26","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamacardio.2023.3803","article-title":"Viability and outcomes with revascularization or medical therapy in ischemic ventricular dysfunction: a prespecified secondary analysis of the REVIVED-BCIS2 trial","volume":"8","author":"Perera","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2024.12.002_bib27","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/CIRCULATIONAHA.123.065300","article-title":"Arrhythmia and death following percutaneous revascularization in ischemic left ventricular dysfunction: prespecified analyses from the REVIVED-BCIS2 trial","volume":"148","author":"Perera","year":"2023","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.hfc.2024.12.002_bib28","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.hfc.2024.12.002_bib29","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.hfc.2024.12.002_bib30","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A\u00a0randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.hfc.2024.12.002_bib31","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1161\/CIRCULATIONAHA.123.067032","article-title":"Nonischemic or dual cardiomyopathy in patients with coronary artery disease","volume":"149","author":"Bawaskar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.12.002_bib32","author":"Ryan"},{"issue":"12","key":"10.1016\/j.hfc.2024.12.002_bib33","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jamacardio.2023.3846","article-title":"Assessment of myocardial viability in ischemic cardiomyopathy\u2014scarred by the data but still alive","volume":"8","author":"Panza","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.002_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12350-017-1110-x","article-title":"Clinical quantification of myocardial blood flow using PET: joint position paper of the SNMMI cardiovascular council and the ASNC","volume":"25","author":"Murthy","year":"2018","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.002_bib35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/eurheartj\/ehz389","article-title":"Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization","volume":"41","author":"Patel","year":"2020","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.hfc.2024.12.002_bib36","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","article-title":"Effects of sex on coronary microvascular dysfunction and cardiac outcomes","volume":"129","author":"Murthy","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.hfc.2024.12.002_bib37","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/jcm10091848","article-title":"Coronary microvascular dysfunction: PET, CMR and CT assessment","volume":"10","author":"Tonet","year":"2021","journal-title":"JCM"},{"issue":"21","key":"10.1016\/j.hfc.2024.12.002_bib38","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options","volume":"72","author":"Taqueti","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.hfc.2024.12.002_bib39","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1136\/heartjnl-2019-315183","article-title":"Positron emission tomography imaging in cardiovascular disease","volume":"106","author":"Tarkin","year":"2020","journal-title":"Heart"},{"issue":"24","key":"10.1016\/j.hfc.2024.12.002_bib40","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2016.09.953","article-title":"18 F-sodium fluoride PET\/MR for the assessment of cardiac amyloidosis","volume":"68","author":"Trivieri","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.002_bib41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"[18F]-Florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions","volume":"14","author":"Genovesi","year":"2021","journal-title":"JACC Cardiovascular Imaging"},{"issue":"Supplement 2","key":"10.1016\/j.hfc.2024.12.002_bib42","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.2967\/jnumed.122.264866","article-title":"Molecular imaging of systemic and cardiac amyloidosis: recent advances and focus on the future","volume":"64","author":"Dorbala","year":"2023","journal-title":"J\u00a0Nucl Med"},{"issue":"11","key":"10.1016\/j.hfc.2024.12.002_bib43","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac amyloid detection by PET\/CT imaging of iodine (124I) evuzamitide (124I-p5+14)","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovascular Imaging"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.002_bib44","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI\u2013ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.002_bib45","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","article-title":"Isolated cardiac sarcoidosis: a focused review of an under-recognized entity","volume":"25","author":"Okada","year":"2018","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"21","key":"10.1016\/j.hfc.2024.12.002_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001240","article-title":"Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American heart association","volume":"149","author":"Cheng","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.002_bib47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.002_bib48","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s12350-019-01786-w","article-title":"Characterization of a highly effective preparation for suppression of myocardial glucose utilization","volume":"27","author":"Larson","year":"2020","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.002_bib49","first-page":"770","article-title":"Comparison of exogenous ketone administration versus dietary carbohydrate restriction on myocardial glucose suppression: a crossover clinical trial","volume":"63","author":"Selvaraj","year":"2022","journal-title":"J\u00a0Nucl Med"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.002_bib50","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1097\/RLU.0000000000003556","article-title":"An intravenous 100-mL lipid emulsion infusion dramatically improves myocardial glucose metabolism extinction in cardiac FDG PET clinical practice","volume":"46","author":"Dietz","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.hfc.2024.12.002_bib51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18 F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J\u00a0Nucl Med"},{"issue":"6","key":"10.1016\/j.hfc.2024.12.002_bib52","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s12350-018-01541-7","article-title":"18F-FDG uptake of the right ventricle is an important predictor of histopathologic diagnosis by endomyocardial biopsy in patients with cardiac sarcoidosis","volume":"27","author":"Omote","year":"2020","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.002_bib53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.002_bib54","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.002_bib55","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","article-title":"Pre-treatment myocardial 18FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"JACC Cardiovascular Imaging"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.002_bib56","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.002_bib57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2023.11.010","article-title":"Hybrid magnetic resonance positron emission tomography is associated with cardiac-related outcomes in cardiac sarcoidosis","volume":"17","author":"Trivieri","year":"2024","journal-title":"JACC Cardiovascular Imaging"},{"issue":"1","key":"10.1016\/j.hfc.2024.12.002_bib58","article-title":"Clinical utilization of multimodality imaging for myocarditis and cardiac sarcoidosis","volume":"16","author":"Chareonthaitawee","year":"2023","journal-title":"Circ: Cardiovascular Imaging"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.002_bib59","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jcmg.2016.01.010","article-title":"Imaging of inflammation in unexplained cardiomyopathy","volume":"9","author":"Kadkhodayan","year":"2016","journal-title":"JACC Cardiovascular Imaging"},{"issue":"11","key":"10.1016\/j.hfc.2024.12.002_bib60","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jcmg.2017.12.008","article-title":"Diagnostic accuracy of cardiovascular magnetic resonance in acute myocarditis","volume":"11","author":"Kotanidis","year":"2018","journal-title":"JACC Cardiovascular Imaging"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.002_bib61","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s12350-016-0616-y","article-title":"Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET\/MRI","volume":"25","author":"Nensa","year":"2018","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.002_bib62","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1093\/ehjci\/jeae082","article-title":"Complementary role of cardiac magnetic resonance imaging and 18F-FDG-positron emission tomography in myocarditis","volume":"25","author":"Kafil","year":"2024","journal-title":"Eur Heart J Cardiovascul Imag"},{"issue":"8","key":"10.1016\/j.hfc.2024.12.002_bib63","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11886-019-1158-0","article-title":"Assessment of myocarditis: cardiac MR, PET\/CT, or PET\/MR?","volume":"21","author":"Chen","year":"2019","journal-title":"Curr Cardiol Rep"},{"issue":"10","key":"10.1016\/j.hfc.2024.12.002_bib64","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.jcmg.2022.02.029","article-title":"Clinical Applications of FDG-PET scan in arrhythmic myocarditis","volume":"15","author":"Peretto","year":"2022","journal-title":"JACC Cardiovascular Imaging"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.002_bib65","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00259-022-06015-0","article-title":"[68Ga]Ga-DOTA-FAPI-04 PET\/MR in patients with acute myocardial infarction: potential role of predicting left ventricular remodeling","volume":"50","author":"Zhang","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"5","key":"10.1016\/j.hfc.2024.12.002_bib66","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1007\/s12350-021-02603-z","article-title":"Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using 68Ga-FAPI-04","volume":"29","author":"Notohamiprodjo","year":"2022","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"9","key":"10.1016\/j.hfc.2024.12.002_bib67","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.121.263555","article-title":"Cardiac fibroblast activation in patients early after acute myocardial infarction: integration with MR tissue characterization and subsequent functional outcome","volume":"63","author":"Diekmann","year":"2022","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.hfc.2024.12.002_bib68","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/ehjci\/jeac242","article-title":"Emerging molecular imaging targets and tools for myocardial fibrosis detection","volume":"24","author":"Barton","year":"2023","journal-title":"European Heart Journal - Cardiovascular Imaging"},{"issue":"4","key":"10.1016\/j.hfc.2024.12.002_bib69","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2967\/jnumed.123.266858","article-title":"Total-body PET\/CT Applications in cardiovascular diseases: a perspective document of the SNMMI cardiovascular council","volume":"65","author":"Slart","year":"2024","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.hfc.2024.12.002_bib70","series-title":"Nuclear cardiology and multimodal cardiovascular imaging: a companion to braunwald\u2019s heart disease","first-page":"37","article-title":"Radiopharmaceuticals for clinical SPECT and PET and imaging protocols","author":"Miller","year":"2021"},{"key":"10.1016\/j.hfc.2024.12.002_bib71","series-title":"Nuclear cardiology and multimodal cardiovascular imaging: a companion to braunwald\u2019s heart disease","first-page":"318","article-title":"Patient with known or suspected cardiac sarcoidosis","author":"Blankstein","year":"2021"},{"issue":"11","key":"10.1016\/j.hfc.2024.12.002_bib72","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac amyloid quantification using 124I-evuzamitide (124I-P5+14) versus 18F-florbetapir","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovascular Imaging"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T03:05:24Z","timestamp":1750302324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713624000989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1551713624000989"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2024.12.002","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac PET Imaging for Coronary Artery Disease and Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2024.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}